alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 3, 2010, Siegfried (USA), 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug
ScheduleGamma Hydroxybutyric Acid (2010)
IDihydromorphine (9145)
IAmphetamine (1100)
IIMethylphenidate (1724)
IIAmobarbital (2125)
IIPentobarbital (2270)
IISecobarbital (2315)
IIGlutethimide (2550)
IICodeine (9050)
IIOxycodone (9143)
IIHydromorphone (9150)
IIHydrocodone (9193)
IIMethadone (9250)
IIMethadone intermediate (9254)
IIDextropropoxyphene, bulk (non-dosage forms) (9273)
IIMorphine (9300)
IIOxymorphone (9652)
IIOxycodone (9143)
II
 The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, 
                    **Federal Register**
                     Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than February 28, 2011. Dated: December 20, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2010-32855 Filed 12-28-10; 8:45 am] BILLING CODE 4410-09-P
# m8916.docx

EUROPEAN COMMISSION Brussels, 3.7.2018 C(2018) 4373 final To the notifying parties: Subject : Case M.8916 - JIC / TAHL / AUSTRALIA NATURE'S CARE BIOTECH Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC) No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, 1. On 5 June 2018 , the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which China Jianyin Investment Limited ("JIC", China) and Tamar Alliance Health Limited ("TAHL", Cayman Islands) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Australia Nature's Care Biotech Co., Ltd. A ("ANCB", Australia) controlled by Alex Wu and Jina Chen by way of purchase of shares . 3 2. The business activities of the undertakings concerned are: - for JIC: integrated investment group focused on equity investments, with financial service, industrial manufacturing, culture & consumption and information technology as its four main investment areas, - for TAHL: investment vehicle dedicated to investing in consumer and healthcare sectors, - for ANCB: active in manufacturing, marketing, selling, distributing, and exporting vitamins and supplements products and other healthcare products (including skincare and baby care products) across Australia, China and Taiwan. 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5 ( a ) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 . 4 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement . For the Commission
( S igned)
Johannes LAITENBERGER Director - General
(1)
OJ L 24, 29.1.2004, p. 1 ( the ' Merger Regulation ' ). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ( ' TFEU ' ) has introduced certain changes, such as the replacement of ' Community ' by ' Union ' and ' common market ' by ' internal market ' . The terminology of the TFEU will be used throughout this decision.
(2) OJ L 1, 3.1.1994, p. 3 ( the ' EEA Agreement ' ).
(3) Publication in the Official Journal of the European Union No C 205 , 1 4 .6 .2018 , p. 31 .
(4)
OJ C 366, 14.12.2013, p. 5 .
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7103 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7103

To amend the Small Business Act to require Federal agencies to testify 
     and report on scores received under the scorecard program for 
 evaluating Federal agency compliance with small business contracting 
goals, to testify for failure to meet Governmentwide contracting goals, 
                        and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 29, 2024

Mr. Stauber (for himself, Mr. McGarvey, and Mr. LaLota) introduced the 
 following bill; which was referred to the Committee on Small Business

_______________________________________________________________________

                                 A BILL

 
To amend the Small Business Act to require Federal agencies to testify 
     and report on scores received under the scorecard program for 
 evaluating Federal agency compliance with small business contracting 
goals, to testify for failure to meet Governmentwide contracting goals, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Agency Accountability Act of 2024''.

SEC. 2. FEDERAL AGENCY TESTIMONY ON SCORECARD SCORES AND FAILURE TO 
              ACHIEVE CERTAIN GOALS.

    Section 15(g)(2) of the Small Business Act (15 U.S.C. 644(g)(2)) is 
amended by adding at the end the following:
            ``(G) Testimony required.--The head of the office 
        established in a Federal agency under subsection (k) shall 
        testify before the Committee on Small Business and 
        Entrepreneurship of the Senate and the Committee on Small 
        Business of the House of Representatives under the following 
        circumstances:
                    ``(i) If such agency fails to receive a score 
                equivalent to a letter grade of `A' or above on the 
                scorecard established under subsection (y) for a fiscal 
                year, on the reasons for such failure.
                    ``(ii) If such agency fails to meet two or more of 
                the Governmentwide goals established under paragraph 
                (1)(A), on the reasons for such failure,''.

SEC. 3. FEDERAL AGENCY REPORTING ON SCORECARD SCORES.

    Section 15(h)(1)(D) of the Small Business Act (15 U.S.C. 
644(h)(1)(D)) is amended by inserting ``and to improve the score on the 
scorecard established under subsection (y)'' after ``better meet such 
goals''.

SEC. 4. COMPLIANCE WITH CUTGO.

    No additional amounts are authorized to be appropriated to carry 
out this Act or the amendments made by this Act.
                                 <all>
```
EXHIBIT 10.06

                     AMENDMENT #2 TO SECURED PROMISSORY NOTE

New York, New York                                      Effective April 11, 2005

     The  undersigned,  AES Management  Buyout  Company,  Inc. (the  "Borrower")
pursuant to a Secured  Promissory  Note dated September 28, 2004 (the "Note") as
Amended on January 25, 2005,  promised to pay to the order of Embryo Development
Corp.  (the  "Payee") the  principal  amount of $300,000  together with interest
thereon at the rate of eight (8%) percent per annum from the date thereof.

     The Note was made in  conjunction  with a certain  Letter  of Intent  dated
August 4, 2004 (the  "LOI") and is secured by a Security  Agreement  in favor of
the Payee, as described therein.

     Except as otherwise  specifically  agreed to in this amendment,  all terms,
conditions  and  provisions  of the Note and Security  Agreement,  as previously
amended are hereby affirmed and shall remain in full force and effect.  Further,
all terms not otherwise  defined in this Amendment shall be deemed to be defined
as in the Note.

     The Borrower, by execution hereof, acknowledges that a Definitive Agreement
as  contemplated by the LOI was not executed by March 15, 2005, and the Maturity
Date  has  been  accelerated  and  accrued  interest  due on the Note is due and
payable on April 15, 2005.

     Subject to delivery to Payee by Borrower of a payment against the principal
of the Note of  $50,000,  in good  funds,  no later  than  April 15,  2005,  the
Maturity  Date  shall be  extended  to June 15,  2005,  for the  balance  of the
principal and all accrued interest on the Note.

     By signing below Borrower and Payee hereby agree to the foregoing amendment
to the Note, effective immediately.

     IN WITNESS  WHEREOF,  the parties  have set their hands as of the day first
set forth above.

AES Management Buyout Company           Embryo Development Corp.



By: /s/                                 By:/s/
    -------------------------              ---------------------
### Ground-water resources of the Jenkins-Whitesburg area, Kentucky

By: D. S. Mull

                            https://doi.org/10.3133/wsp1809A

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plates:                               - **Plate 1**                            (pdf)
  - **Plate 2**                            (pdf) 
- NGMDB Index Page:  **National Geologic Map Database Index Page**
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

No abstract available.

#### Study Area

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
<PAGE>   1

                                                                      EXHIBIT 21

                     LIST OF SUBSIDIARIES OF THE REGISTRANT

        The following entities are owned directly, or indirectly, by T&W 
Financial Corporation:

Polyjohn Financial, L.L.C., a Washington limited liability company

Member Services Company, L.L.C., a Washington limited liability company

T&W/Commercial Financial Services L.L.C., a Delaware limited liability company

First Financial Leasing Company, L.L.C., a Washington limited liability company

Dodd Pacific Capital Resources, L.L.C., a Washington limited liability company

Prime One Capital Company, L.L.C., a Washington limited liability company

Onset Capital Corporation, an Alberta corporation

806285 Alberta Ltd., an Alberta corporation

T & W Funding Company I, L.L.C., a Delaware limited liability company*

T & W Funding Company II, L.L.C., a Delaware limited liability company*

T & W Funding Company IV, L.L.C., a Delaware limited liability company*

T & W Funding Company V, L.L.C., a Delaware limited liability company*

T & W Funding Company VII, L.L.C., a Delaware limited liability company*

T & W Funding Company VIII, L.L.C., a Delaware limited liability company*

T & W Funding Company IX, L.L.C., a Delaware limited liability company*

T & W Funding Company X, L.L.C., a Delaware limited liability company*

T & W Funding Company XI, L.L.C., a Delaware limited liability company*

T & W Funding Company XII, L.L.C., a Delaware limited liability company*
-------------------------------------------------------------------------------
*Special purpose entities formed in connection with lease securitizations.
38443.

#### GLOVER v. MADDOX *et al.*

Frankum, Judge.

This case has been tried three times in Floyd Superior Court. The first two trials resulted in verdicts for the plaintiff which were reversed in *Glover v. Maddox,*98 Ga. App. 548 (106 S. E. 2d 288), and *Glover v. Maddox,*100 Ga. App. 262 (111 S. E. 2d 164), to which *426reference is made for a detailed statement of facts. On the third trial a verdict was returned for the defendant. The plaintiff filed a motion for a new trial and later amended to add one special ground. On April 29, 1960, after argument of counsel, the trial judge granted the motion for a new trial, and to such ruling the defendant excepts and assigns same as error.

Decided September 23, 1960.

*Cook*(fc *Palmour, A. Cecil Palmour,*for plaintiff in error.

*Glower & Anderson, Fullbright & Duffey, Iienry J. Fullbright, Jr.,*contra.

The evidence in the instant case is not vastly different from that on the prior trials. The plaintiff testified that he did not agree to a specific contingent fee of $5,000, to be associated with the defendant in a case. On the contrary, the defendant testified that the plaintiff did agree to the specific fee. Suffice it to say, the evidence did not demand a finding for the plaintiff or for the defendant. Under the ruling of *Dennard v. Styles,*101 Ga. App. 459 (114 S. E. 2d 317) (and cases cited therein), the trial judge has now exercised his discretion to grant a new trial, and we cannot find that he has abused such discretion.

*Judgment affirmed.*

*Gardner, P. J., Townsend and Carlisle, JJ., concur.*
Exhibit
32.1


CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Atlantis Technology Group (the
"Company") on Form 10-Q for the quarter ended June 30, 2008, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I
Christopher M. Dubeau, Chief Executive Officer and Principal Financial Officer,
Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, to the best of my knowledge, that:





(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and






(2) The
information contained in the report fairly presents, in all material respects,
the financial condition and results of operations of the Company.








Date:
November 14, 2008





By:








Christopher
M. Dubeau, Chief Executive Officer


and
Principal Financial Officer, Principal Accounting Officer
PGI 239.71 -SECURITY AND PRIVACY FOR COMPUTER SYSTEMS    **Parent topic:** PGI Part 239 - ACQUISITION OF INFORMATION TECHNOLOGYPGI 239.7102 Policy and responsibilities.    PGI 239.7102-3 Information assurance contractor training and certification.       (1) The designated contracting officer’s representative will document the current information assurance certification status of contractor personnel by category and level, in the Defense Eligibility Enrollment Reporting System, as required by DoD Manual 8570.01-M, Information Assurance Workforce Improvement Program.          (2) DoD 8570.01-M, paragraphs C3.2.4.8.1 and C4.2.3.7.1, requires modification of existing contracts to specify contractor training and certification requirements, in accordance with the phased implementation plan in Chapter 9 of DoD 8570.01-M. As with all modifications, any change to contract requirements shall be with appropriate consideration.
#### § 1312.24 Distribution of export permit.

The Administration shall transmit the export permit to the competent national authority of the importing country and shall make available to the exporter an official record of the export permit through secure electronic means. The exporter, or their agent, must submit an official record of the export permit and/or required data concerning the export transaction to a customs officer at the port of export in compliance with all export control requirements of agencies with export control authorities under the Act or statutory authority other than the Controlled Substances Import and Export Act. The exporter must maintain an official record of the export permit (available from the secure network application on the DEA Diversion Control Division Web site after the Administration issues a transaction identification number) in accordance with part 1304 of this chapter as the record of authority for the exportation and shall transmit an official record of the export permit to the foreign importer. The exporter must ensure that an official record of the permit accompanies the shipment to its final destination. No shipment of controlled substances denied release for any reason shall be allowed to be released from the United States without subsequent authorization from the Administration.

[81 FR 97032, Dec. 30, 2016]
| (logo) WELLS FARGO | CMBS Department

 MAC N9401-011

1055 10th Avenue SE

Minneapolis, MN 55414 |
|--------------------|-----------------------------------------------------------------------------|

 

Morgan Stanley Capital I Inc.

1585 Broadway

New York, New York 10036

 

 

RE: Annual Statement of Compliance for Morgan Stanley Bank of America Merrill Lynch Trust 2013-C9, Commercial Mortgage Pass-Through Certificates Series 2013-C9

 

Per the Pooling and Servicing Agreement dated as of May 1, 2013 (the "Agreement"), the undersigned, a duly authorized officer of Wells Fargo Bank, N.A., as Custodian ("Wells Fargo"), hereby certifies as follows as of and for the year ending December 31, 2015 (the "Reporting Period"):

 

(a) A review of Wells Fargo's activities during the Reporting Period and of its performance under the Agreement has been made under such officer's supervision; and

 

(b) To the best of such officer's knowledge, based on such review, Wells Fargo has fulfilled all of its obligations under the Agreement in all material respects throughout the Reporting Period.

 

 

February 29, 2016

/s/ Gail Vannest

GAIL VANNEST

Vice President

 

 

Wells Fargo Bank, N.A.
Exhibit
      10.14 A







As
                    of October 30, 2006
 
 
 Level
          8
          Systems, Inc.
 8000
          Regency Parkway
 Cary,
          NC
          27511
 
 Gentlemen:
 
 We
          are
          pleased to advise that Bank Hapoalim B.M. (the “Bank”) has agreed, subject to
          the conditions set forth below, to extend the maturity date of the existing
          loan
          (the “Loan”) to Level 8 Systems, Inc. **** (the
          “Borrower”) in the amount of $1,971,000.00. The Loan shall mature on October 31,
          2007. The effectiveness of the renewal of the Loan is subject to the Bank’s
          receipt of such documentation as it may request, including without limitation,
          the following each in form and substance satisfactory to the Bank: (1)
          this
          Letter Agreement, (2) Amendment No. 1 to the existing Promissory Note dated
          as
          of November 3, 2005 executed by the Borrower in favor of the Bank together
          with
          the Late Payment Rider attached thereto, (3) a Letter of Undertaking from
          Bank
          Hapoalim Hagalim Branch in the aggregate amount of $1,971,000.00 and (4)
          any
          other documents as the Bank may require. The Borrower shall pay the Bank
          an
          amendment fee in the amount of $1,000.00.
 
 Please
          indicate your acknowledgment of and agreement to the foregoing by signing
          and
          returning the enclosed copy of this letter to the attention of Maxine Levy,
          Vice
          President.
 
 Very
                    truly yours,Acknowledged
                    and Agreed to:
                
                **BANK
                    HAPOALIM B.M.****LEVEL
                    8 SYSTEMS, INC.**By:By:
                
                
                
                Title:Title:By:By:
                
                
                
                Title:Title:
 ***New
        York Branches***
 
 1177
        Avenue of the Americas New York NY 10036-2790
 T.
        212
        782 2000  F. 212 782 2222  www.hapoalimusa.com